Cytotoxicity and rapid uptake of antioxidants loaded onto solid lipid nanocarriers in MCF-7 and SK-Br-3 breast cancer cells

Document Type : Research Paper

Authors

1 Nano Drug Delivery Research Center, Faculty of Pharmacy, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran

3 Universita Gegli Studi Di Parma, Facolta Di Farmacia, Italia

4 Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

5 Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Objective(s): To eliminate the side effects of anti-cancer medications, the master plan is to use the nano-drug delivery system to deliver two or more anti-cancer medicines. This study aimed to use a binary drug delivery system to deliver Resveratrol (RES) and Tretinoin (TTN) to breast cancer cells and assess the effectiveness of this approach on two types of breast cancer cells (MCF-7 and SK-Br-3). 
Materials and Methods: Binary-drug Solid Lipid Nanocarrier (SLN) formation was confirmed through dynamic light scattering (DLS), Fourier-transform infrared spectroscopy (FTIR), UV-vis spectrophotometers, and scanning electron microscopy (SEM).  In this study, both breast cancer cell lines were cultured under various concentrations of free and dual drug (RES+TTN)-SLN. 
Results: In vitro anticancer analysis, including MTT and quantitative reverse transcription-PCR (qRT-PCR) assays, revealed lower cell viability rates in both breast cancer cell lines compared with the control. Additionally, antiapoptotic-related genes were up-regulated and apoptotic-related genes were down-regulated when MCF-7 and SK-Br-3 were treated with RES+TTN-SLN. Furthermore, dual-encapsulation of RES and TTN significantly reduced cell viability percentage, even at the lowest concentrations (1 and 5 uM) compared with free drug and control groups for 48 hr. To sum it up, dual delivery systems of RES and TTN by SLN can deliver the optimal dose of RES and TTN into both MCF-7 and SK-Br-3 cell lines. 
Conclusion: Conclusively, RES+TTN-SLN even at the lowest concentration (1 μM and 5 μM) showed a synergistic anti-cancer effect in MCF-7 and SK-Br-3 with a better enhancement of apoptotic gene expression by enhanced/controlled intracellular penetration.

Keywords

References

1.    He B, Sui X, Yu B, Wang S, Shen Y, Cong H. Recent advances in drug delivery systems for enhancing drug penetration into tumors. Drug Deliv. 2020;27(1):1474-90.
2.    Ryser MD, Lange J, Inoue LY, O’Meara ES, Gard C, Miglioretti DL, et al. Estimation of breast cancer overdiagnosis in a US breast screening cohort. Ann. Intern. Med. 2022; 175(4):471-478
3.    Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M. Surgical treatments of hepatobiliary cancers. J. Hepatol. 2021;73:128-36.
4.    Ellis C, Millikan L, Smith E, Chalker D, Swinyer L, Katz I, et al. Comparison of adapalene 0· 1% solution and tretinoin 0· 025% gel in the topical treatment of acne vulgaris. Br. J. Dermatol. 1998;139(52):41-47
5.    Dehaghani MZ, Yousefi F, Seidi F, Bagheri B, Mashhadzadeh AH, Naderi G, et al. Encapsulation of an anticancer drug Isatin inside a host nano-vehicle SWCNT: a molecular dynamics simulation. Sci. Rep. 2021;11(1):1-10.
6.    Amer Ridha A, Kashanian S, Rafipour R, Hemati Azandaryani A, Zhaleh H, Mahdavian E. A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate–apoferritin-conjugated cationic solid lipid nanoparticles. Pharm Dev Technol. 2021;26(6):673-81.
7.    Zhang Y, Uthaman S, Song W, Eom KH, Jeon SH, Huh KM, et al. Multistimuli-responsive polymeric vesicles for accelerated drug release in chemo-photothermal therapy. ACS Biomater. Sci. Eng. 2020;6(9):5012-23.
8.    Aghaz F, Vaisi-Raygani A, Khazaei M, Arkan E, Sajadimajd S, Mozafari H, et al. Co-encapsulation of tertinoin and resveratrol by solid lipid nanocarrier (SLN) improves mice in vitro matured oocyte/morula-compact stage embryo development. Theriogenology. 2021;171:1-13.
9.    Motiei M, Kashanian S. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs. Eur. J. Pharm. Sci. 2017;99:285-91.
10.    Herndl GJ, Kaltenböck E, Müller-Niklas G. Dialysis bag incubation as a nonradiolabeling technique to estimate bacterioplankton production in situ.  Handbook of Methods in Aquatic Microbial Ecology: CRC Press; 2018; 4(1): 553-556.
11.    Dhivya S, Gayatri Devi R, Selvaraj J, Jothi Priya A. Regulation of Chloride Intracellular Channel Protein 1 and Caspase-3 mRNA Expression by Hydroethanolic Extract of Aegle marmelos Fruit Human Breast Cancer Cell Line-MCF-7. J. Pharm. Res. Int. 2021;33(47):587-593
12.    Biresaw SS, Taneja P. Copper nanoparticles green synthesis and characterization as anticancer potential in breast cancer cells (MCF7) derived from Prunus nepalensis phytochemicals. Materials Today: Proceedings. J. Pharm. Res. Int. 2022;49:3501-3509.
13.    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402-408.
14.    Xiao H, Song H, Yang Q, Cai H, Qi R, Yan L, et al. A prodrug strategy to deliver cisplatin (IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials. 2012;33(27):6507-19.
15.    Totten SP, Im YK, Cepeda Cañedo E, Najyb O, Nguyen A, Hébert S, et al. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer. Nat. Commun. 2021;12(1):1-20.
16.    Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, et al. Antioxidants for the treatment of breast cancer: Are we there yet? Antioxidants. 2021;10(2):205.
17.    Carbone C, Fuochi V, Zielińska A, Musumeci T, Souto E, Bonaccorso A, et al. Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis. Colloids Surf. B. 2020;186:110705.
18.    Huo M, Wang H, Zhang Y, Cai H, Zhang P, Li L, et al. Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. JCR.2020;32(10):198-210
19.    Campos J, Severino P, Santini A, Silva A, Shegokar R, Souto S, et al. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties. Nanopharmaceuticals. 2020;10(1):1-15.
20.    Gaber M, Elhasany KA, Sabra S, Helmy MW, Fang J-Y, Khattab SN, et al. Co-administration of tretinoin enhances the anti-cancer efficacy of etoposide via tumor-targeted green nano-micelles. Colloids Surf. B. 2020;192(1):110997.
21.    Abdel-Hakeem MA, Mongy S, Hassan B, Tantawi OI, Badawy I. Curcumin Loaded Chitosan-Protamine Nanoparticles Revealed Antitumor Activity Via Suppression of NF-κB, Proinflammatory Cytokines and Bcl-2 Gene Expression in the Breast Cancer Cells. J. Pharm. Sci. 2021;110(9):3298-305.
22.    Gupta DD, Mishra S, Verma SS, Shekher A, Rai V, Awasthee N, et al. Evaluation of antioxidant, anti-inflammatory and anticancer activities of diosgenin enriched Paris polyphylla rhizome extract of Indian Himalayan landraces. J. Ethnopharmacol. 2021;270:113842.
Nanomedicine Journal
Volume 10, Issue 1
January 2023
Pages 59-67

Files

Share

How to cite

Statistics